Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arellano Edwin CevallosfiledCriticalArellano Edwin Cevallos
Priority to ECSP982461priorityCriticalpatent/ECSP982461A/es
Publication of ECSP982461ApublicationCriticalpatent/ECSP982461A/es
Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa- 4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14- dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
"Utilisation de la N-myristoyl-(S)-phénylalaine pour l'obtention de médicaments destinés au traitement des maladies faisant intervenir la myristoylation".
Dihidrato del (2r-3s)-3-ter-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4,10 beta-diacetoxi-2 alfa, -benzoiloxi-5beta, 20-epoxi -1-hidroxi-9-oxo-19-norciclopropa [g]tax-11-eno-13alfa-ilo y su procedimiento de preparacion.